Links to Exploration step
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">The International ADHD in Substance Use Disorders Prevalence (IASP) study: background, methods and study population</title><author><name sortKey="Van De Glind, Geurt" sort="Van De Glind, Geurt" uniqKey="Van De Glind G" first="Geurt" last="Van De Glind">Geurt Van De Glind</name><affiliation><nlm:aff id="A1">Trimbos-instituut and ICASA Foundation, Utrecht, The Netherlands</nlm:aff></affiliation><affiliation><nlm:aff id="A3">Amsterdam Institute for Addiction research, Department of Psychiatry, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands</nlm:aff></affiliation></author><author><name sortKey="Van Emmerik Van Oortmerssen, Katelijne" sort="Van Emmerik Van Oortmerssen, Katelijne" uniqKey="Van Emmerik Van Oortmerssen K" first="Katelijne" last="Van Emmerik-Van Oortmerssen">Katelijne Van Emmerik-Van Oortmerssen</name><affiliation><nlm:aff id="A2">Arkin, Amsterdam, The Netherlands</nlm:aff></affiliation><affiliation><nlm:aff id="A3">Amsterdam Institute for Addiction research, Department of Psychiatry, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands</nlm:aff></affiliation></author><author><name sortKey="Carpentier, Pieter Jan" sort="Carpentier, Pieter Jan" uniqKey="Carpentier P" first="Pieter Jan" last="Carpentier">Pieter Jan Carpentier</name><affiliation><nlm:aff id="A4">Reinier van Arkel groep, ‘s-Hertogenbosch, The Netherlands</nlm:aff></affiliation></author><author><name sortKey="Levin, Frances R" sort="Levin, Frances R" uniqKey="Levin F" first="Frances R." last="Levin">Frances R. Levin</name><affiliation><nlm:aff id="A5">Columbia University/The New York State Psychiatric Institute, New York, USA</nlm:aff></affiliation></author><author><name sortKey="Koeter, Maarten W J" sort="Koeter, Maarten W J" uniqKey="Koeter M" first="Maarten W. J." last="Koeter">Maarten W. J. Koeter</name><affiliation><nlm:aff id="A3">Amsterdam Institute for Addiction research, Department of Psychiatry, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands</nlm:aff></affiliation></author><author><name sortKey="Barta, Csaba" sort="Barta, Csaba" uniqKey="Barta C" first="Csaba" last="Barta">Csaba Barta</name><affiliation><nlm:aff id="A6">Institute of Psychology, Eötvös Loránd University, Budapest, Hungary</nlm:aff></affiliation></author><author><name sortKey="Kaye, Sharlene" sort="Kaye, Sharlene" uniqKey="Kaye S" first="Sharlene" last="Kaye">Sharlene Kaye</name><affiliation><nlm:aff id="A7">National Drug and Alcohol Research Centre, University of New South Wales, Sydney, Australia</nlm:aff></affiliation></author><author><name sortKey="Skutle, Arvid" sort="Skutle, Arvid" uniqKey="Skutle A" first="Arvid" last="Skutle">Arvid Skutle</name><affiliation><nlm:aff id="A8">Bergen Clinics Foundation, Bergen, Norway</nlm:aff></affiliation></author><author><name sortKey="Franck, Johan" sort="Franck, Johan" uniqKey="Franck J" first="Johan" last="Franck">Johan Franck</name><affiliation><nlm:aff id="A9">Department of Clinical Neuroscience, Division of Psychiatry, Karolinska Institutet, Stockholm, Sweden</nlm:aff></affiliation></author><author><name sortKey="Konstenius, Maija" sort="Konstenius, Maija" uniqKey="Konstenius M" first="Maija" last="Konstenius">Maija Konstenius</name><affiliation><nlm:aff id="A9">Department of Clinical Neuroscience, Division of Psychiatry, Karolinska Institutet, Stockholm, Sweden</nlm:aff></affiliation></author><author><name sortKey="Bu, Eli Torild" sort="Bu, Eli Torild" uniqKey="Bu E" first="Eli-Torild" last="Bu">Eli-Torild Bu</name><affiliation><nlm:aff id="A8">Bergen Clinics Foundation, Bergen, Norway</nlm:aff></affiliation></author><author><name sortKey="Moggi, Franz" sort="Moggi, Franz" uniqKey="Moggi F" first="Franz" last="Moggi">Franz Moggi</name><affiliation><nlm:aff id="A10">University Hospital of Psychiatry Berne and Department of Psychology, University of Fribourg, Switzerland</nlm:aff></affiliation></author><author><name sortKey="Dom, Geert" sort="Dom, Geert" uniqKey="Dom G" first="Geert" last="Dom">Geert Dom</name><affiliation><nlm:aff id="A11">Collaborative Antwerp Psychiatry Research Institute (CAPRI, UA), PC Alexian Brothers, Boechout, Belgium</nlm:aff></affiliation></author><author><name sortKey="Demetrovics, Zolt" sort="Demetrovics, Zolt" uniqKey="Demetrovics Z" first="Zolt" last="Demetrovics">Zolt Demetrovics</name><affiliation><nlm:aff id="A6">Institute of Psychology, Eötvös Loránd University, Budapest, Hungary</nlm:aff></affiliation></author><author><name sortKey="Fatseas, Melina" sort="Fatseas, Melina" uniqKey="Fatseas M" first="Mélina" last="Fatséas">Mélina Fatséas</name><affiliation><nlm:aff id="A12">Laboratoire de psychiatrie Département d’addictologie, Université de Bordeaux, France</nlm:aff></affiliation></author><author><name sortKey="Schillinger, Arild" sort="Schillinger, Arild" uniqKey="Schillinger A" first="Arild" last="Schillinger">Arild Schillinger</name><affiliation><nlm:aff id="A13">Østfold Hospital Trust, Department for Substance abuse treatment, Norway</nlm:aff></affiliation></author><author><name sortKey="Kapitany Foveny, Mate" sort="Kapitany Foveny, Mate" uniqKey="Kapitany Foveny M" first="Máté" last="Kapitány-Fövény">Máté Kapitány-Fövény</name><affiliation><nlm:aff id="A6">Institute of Psychology, Eötvös Loránd University, Budapest, Hungary</nlm:aff></affiliation></author><author><name sortKey="Verspreet, Sofie" sort="Verspreet, Sofie" uniqKey="Verspreet S" first="Sofie" last="Verspreet">Sofie Verspreet</name><affiliation><nlm:aff id="A11">Collaborative Antwerp Psychiatry Research Institute (CAPRI, UA), PC Alexian Brothers, Boechout, Belgium</nlm:aff></affiliation></author><author><name sortKey="Seitz, Andrea" sort="Seitz, Andrea" uniqKey="Seitz A" first="Andrea" last="Seitz">Andrea Seitz</name><affiliation><nlm:aff id="A14">University Hospital of Psychiatry, Berne, Switzerland</nlm:aff></affiliation></author><author><name sortKey="Johnson, Brian" sort="Johnson, Brian" uniqKey="Johnson B" first="Brian" last="Johnson">Brian Johnson</name><affiliation><nlm:aff id="A15">Departments of Psychiatry and of Neuroscience and Physiology, SUNY Upstate Medical University, Syracuse, NY, USA</nlm:aff></affiliation></author><author><name sortKey="Faraone, Stephen V" sort="Faraone, Stephen V" uniqKey="Faraone S" first="Stephen V." last="Faraone">Stephen V. Faraone</name><affiliation><nlm:aff id="A15">Departments of Psychiatry and of Neuroscience and Physiology, SUNY Upstate Medical University, Syracuse, NY, USA</nlm:aff></affiliation></author><author><name sortKey="Ramos Quiroga, J Antoni" sort="Ramos Quiroga, J Antoni" uniqKey="Ramos Quiroga J" first="J. Antoni" last="Ramos-Quiroga">J. Antoni Ramos-Quiroga</name><affiliation><nlm:aff id="A16">Servei de Psiquiatria, Hospital Universitari Vall d’Hebron, CIBERSAM, Department of Psychiatry, Universitat Autònoma de Barcelona, Barcelona, Spain</nlm:aff></affiliation></author><author><name sortKey="Allsop, Steve" sort="Allsop, Steve" uniqKey="Allsop S" first="Steve" last="Allsop">Steve Allsop</name><affiliation><nlm:aff id="A17">National Drug Research Institute/Curtin University of Technology, Perth, Australia</nlm:aff></affiliation></author><author><name sortKey="Carruthers, Susan" sort="Carruthers, Susan" uniqKey="Carruthers S" first="Susan" last="Carruthers">Susan Carruthers</name><affiliation><nlm:aff id="A17">National Drug Research Institute/Curtin University of Technology, Perth, Australia</nlm:aff></affiliation></author><author><name sortKey="Schoevers, Robert A" sort="Schoevers, Robert A" uniqKey="Schoevers R" first="Robert A." last="Schoevers">Robert A. Schoevers</name><affiliation><nlm:aff id="A18">Department of Psychiatry, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands</nlm:aff></affiliation></author><author><name sortKey="Van Den Brink, Wim" sort="Van Den Brink, Wim" uniqKey="Van Den Brink W" first="Wim" last="Van Den Brink">Wim Van Den Brink</name><affiliation><nlm:aff id="A3">Amsterdam Institute for Addiction research, Department of Psychiatry, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands</nlm:aff></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PMC</idno><idno type="pmid">24022983</idno><idno type="pmc">4085151</idno><idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4085151</idno><idno type="RBID">PMC:4085151</idno><idno type="doi">10.1002/mpr.1397</idno><date when="2013">2013</date><idno type="wicri:Area/Pmc/Corpus">002079</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">002079</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">The International ADHD in Substance Use Disorders Prevalence (IASP) study: background, methods and study population</title><author><name sortKey="Van De Glind, Geurt" sort="Van De Glind, Geurt" uniqKey="Van De Glind G" first="Geurt" last="Van De Glind">Geurt Van De Glind</name><affiliation><nlm:aff id="A1">Trimbos-instituut and ICASA Foundation, Utrecht, The Netherlands</nlm:aff></affiliation><affiliation><nlm:aff id="A3">Amsterdam Institute for Addiction research, Department of Psychiatry, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands</nlm:aff></affiliation></author><author><name sortKey="Van Emmerik Van Oortmerssen, Katelijne" sort="Van Emmerik Van Oortmerssen, Katelijne" uniqKey="Van Emmerik Van Oortmerssen K" first="Katelijne" last="Van Emmerik-Van Oortmerssen">Katelijne Van Emmerik-Van Oortmerssen</name><affiliation><nlm:aff id="A2">Arkin, Amsterdam, The Netherlands</nlm:aff></affiliation><affiliation><nlm:aff id="A3">Amsterdam Institute for Addiction research, Department of Psychiatry, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands</nlm:aff></affiliation></author><author><name sortKey="Carpentier, Pieter Jan" sort="Carpentier, Pieter Jan" uniqKey="Carpentier P" first="Pieter Jan" last="Carpentier">Pieter Jan Carpentier</name><affiliation><nlm:aff id="A4">Reinier van Arkel groep, ‘s-Hertogenbosch, The Netherlands</nlm:aff></affiliation></author><author><name sortKey="Levin, Frances R" sort="Levin, Frances R" uniqKey="Levin F" first="Frances R." last="Levin">Frances R. Levin</name><affiliation><nlm:aff id="A5">Columbia University/The New York State Psychiatric Institute, New York, USA</nlm:aff></affiliation></author><author><name sortKey="Koeter, Maarten W J" sort="Koeter, Maarten W J" uniqKey="Koeter M" first="Maarten W. J." last="Koeter">Maarten W. J. Koeter</name><affiliation><nlm:aff id="A3">Amsterdam Institute for Addiction research, Department of Psychiatry, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands</nlm:aff></affiliation></author><author><name sortKey="Barta, Csaba" sort="Barta, Csaba" uniqKey="Barta C" first="Csaba" last="Barta">Csaba Barta</name><affiliation><nlm:aff id="A6">Institute of Psychology, Eötvös Loránd University, Budapest, Hungary</nlm:aff></affiliation></author><author><name sortKey="Kaye, Sharlene" sort="Kaye, Sharlene" uniqKey="Kaye S" first="Sharlene" last="Kaye">Sharlene Kaye</name><affiliation><nlm:aff id="A7">National Drug and Alcohol Research Centre, University of New South Wales, Sydney, Australia</nlm:aff></affiliation></author><author><name sortKey="Skutle, Arvid" sort="Skutle, Arvid" uniqKey="Skutle A" first="Arvid" last="Skutle">Arvid Skutle</name><affiliation><nlm:aff id="A8">Bergen Clinics Foundation, Bergen, Norway</nlm:aff></affiliation></author><author><name sortKey="Franck, Johan" sort="Franck, Johan" uniqKey="Franck J" first="Johan" last="Franck">Johan Franck</name><affiliation><nlm:aff id="A9">Department of Clinical Neuroscience, Division of Psychiatry, Karolinska Institutet, Stockholm, Sweden</nlm:aff></affiliation></author><author><name sortKey="Konstenius, Maija" sort="Konstenius, Maija" uniqKey="Konstenius M" first="Maija" last="Konstenius">Maija Konstenius</name><affiliation><nlm:aff id="A9">Department of Clinical Neuroscience, Division of Psychiatry, Karolinska Institutet, Stockholm, Sweden</nlm:aff></affiliation></author><author><name sortKey="Bu, Eli Torild" sort="Bu, Eli Torild" uniqKey="Bu E" first="Eli-Torild" last="Bu">Eli-Torild Bu</name><affiliation><nlm:aff id="A8">Bergen Clinics Foundation, Bergen, Norway</nlm:aff></affiliation></author><author><name sortKey="Moggi, Franz" sort="Moggi, Franz" uniqKey="Moggi F" first="Franz" last="Moggi">Franz Moggi</name><affiliation><nlm:aff id="A10">University Hospital of Psychiatry Berne and Department of Psychology, University of Fribourg, Switzerland</nlm:aff></affiliation></author><author><name sortKey="Dom, Geert" sort="Dom, Geert" uniqKey="Dom G" first="Geert" last="Dom">Geert Dom</name><affiliation><nlm:aff id="A11">Collaborative Antwerp Psychiatry Research Institute (CAPRI, UA), PC Alexian Brothers, Boechout, Belgium</nlm:aff></affiliation></author><author><name sortKey="Demetrovics, Zolt" sort="Demetrovics, Zolt" uniqKey="Demetrovics Z" first="Zolt" last="Demetrovics">Zolt Demetrovics</name><affiliation><nlm:aff id="A6">Institute of Psychology, Eötvös Loránd University, Budapest, Hungary</nlm:aff></affiliation></author><author><name sortKey="Fatseas, Melina" sort="Fatseas, Melina" uniqKey="Fatseas M" first="Mélina" last="Fatséas">Mélina Fatséas</name><affiliation><nlm:aff id="A12">Laboratoire de psychiatrie Département d’addictologie, Université de Bordeaux, France</nlm:aff></affiliation></author><author><name sortKey="Schillinger, Arild" sort="Schillinger, Arild" uniqKey="Schillinger A" first="Arild" last="Schillinger">Arild Schillinger</name><affiliation><nlm:aff id="A13">Østfold Hospital Trust, Department for Substance abuse treatment, Norway</nlm:aff></affiliation></author><author><name sortKey="Kapitany Foveny, Mate" sort="Kapitany Foveny, Mate" uniqKey="Kapitany Foveny M" first="Máté" last="Kapitány-Fövény">Máté Kapitány-Fövény</name><affiliation><nlm:aff id="A6">Institute of Psychology, Eötvös Loránd University, Budapest, Hungary</nlm:aff></affiliation></author><author><name sortKey="Verspreet, Sofie" sort="Verspreet, Sofie" uniqKey="Verspreet S" first="Sofie" last="Verspreet">Sofie Verspreet</name><affiliation><nlm:aff id="A11">Collaborative Antwerp Psychiatry Research Institute (CAPRI, UA), PC Alexian Brothers, Boechout, Belgium</nlm:aff></affiliation></author><author><name sortKey="Seitz, Andrea" sort="Seitz, Andrea" uniqKey="Seitz A" first="Andrea" last="Seitz">Andrea Seitz</name><affiliation><nlm:aff id="A14">University Hospital of Psychiatry, Berne, Switzerland</nlm:aff></affiliation></author><author><name sortKey="Johnson, Brian" sort="Johnson, Brian" uniqKey="Johnson B" first="Brian" last="Johnson">Brian Johnson</name><affiliation><nlm:aff id="A15">Departments of Psychiatry and of Neuroscience and Physiology, SUNY Upstate Medical University, Syracuse, NY, USA</nlm:aff></affiliation></author><author><name sortKey="Faraone, Stephen V" sort="Faraone, Stephen V" uniqKey="Faraone S" first="Stephen V." last="Faraone">Stephen V. Faraone</name><affiliation><nlm:aff id="A15">Departments of Psychiatry and of Neuroscience and Physiology, SUNY Upstate Medical University, Syracuse, NY, USA</nlm:aff></affiliation></author><author><name sortKey="Ramos Quiroga, J Antoni" sort="Ramos Quiroga, J Antoni" uniqKey="Ramos Quiroga J" first="J. Antoni" last="Ramos-Quiroga">J. Antoni Ramos-Quiroga</name><affiliation><nlm:aff id="A16">Servei de Psiquiatria, Hospital Universitari Vall d’Hebron, CIBERSAM, Department of Psychiatry, Universitat Autònoma de Barcelona, Barcelona, Spain</nlm:aff></affiliation></author><author><name sortKey="Allsop, Steve" sort="Allsop, Steve" uniqKey="Allsop S" first="Steve" last="Allsop">Steve Allsop</name><affiliation><nlm:aff id="A17">National Drug Research Institute/Curtin University of Technology, Perth, Australia</nlm:aff></affiliation></author><author><name sortKey="Carruthers, Susan" sort="Carruthers, Susan" uniqKey="Carruthers S" first="Susan" last="Carruthers">Susan Carruthers</name><affiliation><nlm:aff id="A17">National Drug Research Institute/Curtin University of Technology, Perth, Australia</nlm:aff></affiliation></author><author><name sortKey="Schoevers, Robert A" sort="Schoevers, Robert A" uniqKey="Schoevers R" first="Robert A." last="Schoevers">Robert A. Schoevers</name><affiliation><nlm:aff id="A18">Department of Psychiatry, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands</nlm:aff></affiliation></author><author><name sortKey="Van Den Brink, Wim" sort="Van Den Brink, Wim" uniqKey="Van Den Brink W" first="Wim" last="Van Den Brink">Wim Van Den Brink</name><affiliation><nlm:aff id="A3">Amsterdam Institute for Addiction research, Department of Psychiatry, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands</nlm:aff></affiliation></author></analytic><series><title level="j">International journal of methods in psychiatric research</title><idno type="ISSN">1049-8931</idno><idno type="eISSN">1557-0657</idno><imprint><date when="2013">2013</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><p id="P1">Attention deficit/hyperactivity disorder (ADHD) is an increasingly recognized comorbid condition in subjects with substance use disorders (SUDs).</p><p id="P2">This paper describes the methods and study population of the International ADHD in Substance Use Disorders Prevalence (IASP) study. Objectives of the IASP are to determine the prevalence of ADHD in adult treatment seeking patients with SUD in different countries and SUD populations, determine the reliability and validity of the Adult ADHD Self-report Scale V 1.1 (ASRS) as ADHD screening instrument in SUD populations, investigate the comorbidity profile of SUD patients with and without ADHD, compare risk factors and protective factors in SUD patients with and without a comorbid diagnosis of ADHD, and increase our knowledge about the relationship between ADHD and the onset and course of SUD.</p><p id="P3">In this cross-sectional, multi-centre two stage study, subjects were screened for ADHD with the ASRS, diagnosed with the Conner’s Adult ADHD Diagnostic Interview for DSM-IV (CAADID), and evaluated for SUD, major depression, bipolar disorder, anti social personality disorder and borderline personality disorder.</p><p id="P4">Three thousand five hundred and fifty-eight subjects from 10 countries were included. Of these 40.9% screened positive for ADHD.</p><p id="P5">This is the largest international study on this population evaluating ADHD and comorbid disorders. Copyright © 2013 John Wiley & Sons, Ltd.</p></div></front></TEI><pmc article-type="research-article"><pmc-comment>The publisher of this article does not allow downloading of the full text in XML form.</pmc-comment>
<pmc-dir>properties manuscript</pmc-dir>
<front><journal-meta><journal-id journal-id-type="nlm-journal-id">9111433</journal-id><journal-id journal-id-type="pubmed-jr-id">30082</journal-id><journal-id journal-id-type="nlm-ta">Int J Methods Psychiatr Res</journal-id><journal-id journal-id-type="iso-abbrev">Int J Methods Psychiatr Res</journal-id><journal-title-group><journal-title>International journal of methods in psychiatric research</journal-title></journal-title-group><issn pub-type="ppub">1049-8931</issn><issn pub-type="epub">1557-0657</issn></journal-meta><article-meta><article-id pub-id-type="pmid">24022983</article-id><article-id pub-id-type="pmc">4085151</article-id><article-id pub-id-type="doi">10.1002/mpr.1397</article-id><article-id pub-id-type="manuscript">NIHMS598069</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>The International ADHD in Substance Use Disorders Prevalence (IASP) study: background, methods and study population</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Van De Glind</surname><given-names>Geurt</given-names></name><xref ref-type="aff" rid="A1">1</xref><xref ref-type="aff" rid="A3">3</xref></contrib><contrib contrib-type="author"><name><surname>Van Emmerik-Van Oortmerssen</surname><given-names>Katelijne</given-names></name><xref ref-type="aff" rid="A2">2</xref><xref ref-type="aff" rid="A3">3</xref></contrib><contrib contrib-type="author"><name><surname>Carpentier</surname><given-names>Pieter Jan</given-names></name><xref ref-type="aff" rid="A4">4</xref></contrib><contrib contrib-type="author"><name><surname>Levin</surname><given-names>Frances R.</given-names></name><xref ref-type="aff" rid="A5">5</xref></contrib><contrib contrib-type="author"><name><surname>Koeter</surname><given-names>Maarten W.J.</given-names></name><xref ref-type="aff" rid="A3">3</xref></contrib><contrib contrib-type="author"><name><surname>Barta</surname><given-names>Csaba</given-names></name><xref ref-type="aff" rid="A6">6</xref></contrib><contrib contrib-type="author"><name><surname>Kaye</surname><given-names>Sharlene</given-names></name><xref ref-type="aff" rid="A7">7</xref></contrib><contrib contrib-type="author"><name><surname>Skutle</surname><given-names>Arvid</given-names></name><xref ref-type="aff" rid="A8">8</xref></contrib><contrib contrib-type="author"><name><surname>Franck</surname><given-names>Johan</given-names></name><xref ref-type="aff" rid="A9">9</xref></contrib><contrib contrib-type="author"><name><surname>Konstenius</surname><given-names>Maija</given-names></name><xref ref-type="aff" rid="A9">9</xref></contrib><contrib contrib-type="author"><name><surname>Bu</surname><given-names>Eli-Torild</given-names></name><xref ref-type="aff" rid="A8">8</xref></contrib><contrib contrib-type="author"><name><surname>Moggi</surname><given-names>Franz</given-names></name><xref ref-type="aff" rid="A10">10</xref></contrib><contrib contrib-type="author"><name><surname>Dom</surname><given-names>Geert</given-names></name><xref ref-type="aff" rid="A11">11</xref></contrib><contrib contrib-type="author"><name><surname>Demetrovics</surname><given-names>Zolt</given-names></name><xref ref-type="aff" rid="A6">6</xref></contrib><contrib contrib-type="author"><name><surname>Fatséas</surname><given-names>Mélina</given-names></name><xref ref-type="aff" rid="A12">12</xref></contrib><contrib contrib-type="author"><name><surname>Schillinger</surname><given-names>Arild</given-names></name><xref ref-type="aff" rid="A13">13</xref></contrib><contrib contrib-type="author"><name><surname>Kapitány-Fövény</surname><given-names>Máté</given-names></name><xref ref-type="aff" rid="A6">6</xref></contrib><contrib contrib-type="author"><name><surname>Verspreet</surname><given-names>Sofie</given-names></name><xref ref-type="aff" rid="A11">11</xref></contrib><contrib contrib-type="author"><name><surname>Seitz</surname><given-names>Andrea</given-names></name><xref ref-type="aff" rid="A14">14</xref></contrib><contrib contrib-type="author"><name><surname>Johnson</surname><given-names>Brian</given-names></name><xref ref-type="aff" rid="A15">15</xref></contrib><contrib contrib-type="author"><name><surname>Faraone</surname><given-names>Stephen V.</given-names></name><xref ref-type="aff" rid="A15">15</xref></contrib><contrib contrib-type="author"><name><surname>Ramos-Quiroga</surname><given-names>J. Antoni</given-names></name><xref ref-type="aff" rid="A16">16</xref></contrib><contrib contrib-type="author"><name><surname>Allsop</surname><given-names>Steve</given-names></name><xref ref-type="aff" rid="A17">17</xref></contrib><contrib contrib-type="author"><name><surname>Carruthers</surname><given-names>Susan</given-names></name><xref ref-type="aff" rid="A17">17</xref></contrib><contrib contrib-type="author"><name><surname>Schoevers</surname><given-names>Robert A.</given-names></name><xref ref-type="aff" rid="A18">18</xref></contrib><contrib contrib-type="author"><collab>IASP Research Group</collab><xref ref-type="aff" rid="A19">19</xref></contrib><contrib contrib-type="author"><name><surname>Van Den Brink</surname><given-names>Wim</given-names></name><xref ref-type="aff" rid="A3">3</xref></contrib></contrib-group><aff id="A1"><label>1</label>Trimbos-instituut and ICASA Foundation, Utrecht, The Netherlands</aff><aff id="A2"><label>2</label>Arkin, Amsterdam, The Netherlands</aff><aff id="A3"><label>3</label>Amsterdam Institute for Addiction research, Department of Psychiatry, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands</aff><aff id="A4"><label>4</label>Reinier van Arkel groep, ‘s-Hertogenbosch, The Netherlands</aff><aff id="A5"><label>5</label>Columbia University/The New York State Psychiatric Institute, New York, USA</aff><aff id="A6"><label>6</label>Institute of Psychology, Eötvös Loránd University, Budapest, Hungary</aff><aff id="A7"><label>7</label>National Drug and Alcohol Research Centre, University of New South Wales, Sydney, Australia</aff><aff id="A8"><label>8</label>Bergen Clinics Foundation, Bergen, Norway</aff><aff id="A9"><label>9</label>Department of Clinical Neuroscience, Division of Psychiatry, Karolinska Institutet, Stockholm, Sweden</aff><aff id="A10"><label>10</label>University Hospital of Psychiatry Berne and Department of Psychology, University of Fribourg, Switzerland</aff><aff id="A11"><label>11</label>Collaborative Antwerp Psychiatry Research Institute (CAPRI, UA), PC Alexian Brothers, Boechout, Belgium</aff><aff id="A12"><label>12</label>Laboratoire de psychiatrie Département d’addictologie, Université de Bordeaux, France</aff><aff id="A13"><label>13</label>Østfold Hospital Trust, Department for Substance abuse treatment, Norway</aff><aff id="A14"><label>14</label>University Hospital of Psychiatry, Berne, Switzerland</aff><aff id="A15"><label>15</label>Departments of Psychiatry and of Neuroscience and Physiology, SUNY Upstate Medical University, Syracuse, NY, USA</aff><aff id="A16"><label>16</label>Servei de Psiquiatria, Hospital Universitari Vall d’Hebron, CIBERSAM, Department of Psychiatry, Universitat Autònoma de Barcelona, Barcelona, Spain</aff><aff id="A17"><label>17</label>National Drug Research Institute/Curtin University of Technology, Perth, Australia</aff><aff id="A18"><label>18</label>Department of Psychiatry, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands</aff><aff id="A19"><label>19</label>Apart from the authors the following persons participated in this study: Eva Karin Løvaas, Kari Lossius, Anneke van Wamel, Geert Bosma, David Hay, Sara Wallhed, Marc Auriacombe, Marion Malivert, Romain Debrabant, Therese Dahl, Miguel Casas, Constanza Daigre, Rutger-Jan van der Gaag, Atul Beniwal, Louisa Degenhardt, Joanne Cassar, Jesse Young, Merete Möller</aff><author-notes><corresp id="cor1"><bold>Correspondence</bold>: Geurt van de Glind, ICASA Foundation, Da Costakade 45, PO Box 725, 3500 AS Utrecht, The Netherlands. Telephone (+31) 302971101, Fax (+31) 302971111, <email>gglind@trimbos.nl</email></corresp></author-notes><pub-date pub-type="nihms-submitted"><day>5</day><month>6</month><year>2014</year></pub-date><pub-date pub-type="epub"><day>11</day><month>9</month><year>2013</year></pub-date><pub-date pub-type="ppub"><month>9</month><year>2013</year></pub-date><pub-date pub-type="pmc-release"><day>11</day><month>3</month><year>2015</year></pub-date><volume>22</volume><issue>3</issue><fpage>232</fpage><lpage>244</lpage><pmc-comment>elocation-id from pubmed: 10.1002/mpr.1397</pmc-comment>
<permissions><copyright-statement>Copyright © 2013 John Wiley & Sons, Ltd.</copyright-statement><copyright-year>2013</copyright-year></permissions><abstract><p id="P1">Attention deficit/hyperactivity disorder (ADHD) is an increasingly recognized comorbid condition in subjects with substance use disorders (SUDs).</p><p id="P2">This paper describes the methods and study population of the International ADHD in Substance Use Disorders Prevalence (IASP) study. Objectives of the IASP are to determine the prevalence of ADHD in adult treatment seeking patients with SUD in different countries and SUD populations, determine the reliability and validity of the Adult ADHD Self-report Scale V 1.1 (ASRS) as ADHD screening instrument in SUD populations, investigate the comorbidity profile of SUD patients with and without ADHD, compare risk factors and protective factors in SUD patients with and without a comorbid diagnosis of ADHD, and increase our knowledge about the relationship between ADHD and the onset and course of SUD.</p><p id="P3">In this cross-sectional, multi-centre two stage study, subjects were screened for ADHD with the ASRS, diagnosed with the Conner’s Adult ADHD Diagnostic Interview for DSM-IV (CAADID), and evaluated for SUD, major depression, bipolar disorder, anti social personality disorder and borderline personality disorder.</p><p id="P4">Three thousand five hundred and fifty-eight subjects from 10 countries were included. Of these 40.9% screened positive for ADHD.</p><p id="P5">This is the largest international study on this population evaluating ADHD and comorbid disorders. Copyright © 2013 John Wiley & Sons, Ltd.</p></abstract><kwd-group><kwd>ADHD</kwd><kwd>substance use disorders</kwd><kwd>prevalence</kwd><kwd>attention/deficit hyperactivity disorder</kwd></kwd-group></article-meta></front></pmc></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/Pmc/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002079 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Pmc/Corpus/biblio.hfd -nk 002079 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Asie
|area= AustralieFrV1
|flux= Pmc
|étape= Corpus
|type= RBID
|clé=
|texte=
}}
| This area was generated with Dilib version V0.6.33. |  |